The latest issue of FASEB’s Horizons in Bioscience publication, “Liquid Biopsies: A New Way to Diagnose, Understand & Track Cancer,” has just been released. This two-page resource describes a new technology developed to advance cancer treatment.
FASEB’s Horizons in Bioscience is a series of brief, illustrated articles that describe scientific discoveries on the brink of clinical application. The publication has explored CRISPR/Cas technology, organs-on-a-chip, and epigenetics, among other topics. Printed copies of the articles are available at no cost for educational or advocacy purposes and can be requested by visiting the Breakthroughs & Horizons in Bioscience webpage or by contacting FASEB’s Office of Public Affairs at 301-634-7650.
Liquid Biopsies: A New Way to Diagnose, Understand & Track Cancer - Liquid Biopsy enables clinicians to test DNA shed by dying tumors in human fluids to help track cancer progression. By using this innovative technology, physicians can also create highly individualized treatment plans for specific types of cancer. This process complements existing approaches that use surgery, radiation, and chemotherapy to save lives. Read more...